Read + Share
Amedeo Smart
Independent Medical Education
van Beurden W, Mendoza YP, Lange NF, Bosch J, et al. FIB-4 predicts events in compensated advanced chronic liver disease and type 2 diabetes treated with GLP-1-receptor-agonists. J Diabetes Complications 2025;39:108978.PMID: 39999536
Email
LinkedIn
Privacy Policy